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ABSTRACT: Little is known about the complications of needle electromyo-
graphy (EMG) performed on anticoagulated patients, and no guidelines exist
regarding its performance. We conducted an anonymous survey of aca-
demic EMG laboratories in the U.S. to understand current practices and
complications with regard to anticoagulated patients and those receiving
antiplatelet medications. Forty-seven (78%) of 60 EMG laboratories re-
sponded to the survey. Four laboratories (9%) reported at least one hem-
orrhagic complication requiring medical or surgical intervention in an anti-
coagulated patient, whereas none reported a hemorrhagic complication in
patients receiving antiplatelet medications. Ten (21%) reported willingness
to evaluate cranial, paraspinal, and all limb muscles in anticoagulated pa-
tients. This survey suggests that hemorrhagic complications from needle
EMG of anticoagulated patients are rare. It also suggests that needle EMG
of patients receiving antiplatelet therapy is not associated with increased
reports of hemorrhagic complications.
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There may be an increased risk of bleeding compli-
cations associated with needle electromyography
(EMG) of anticoagulated patients. The magnitude
of that risk and how examinations should be modi-
fied to minimize the risk are unclear. Although there
are no practice guidelines by the American Associa-
tion of Neuromuscular and Electrodiagnostic Medi-
cine (AANEM) with respect to needle EMG of anti-
coagulated patients, there is acknowledgement that
patients with an elevated international normalized
ratio (INR) or low platelet count may be at increased
risk for bleeding complications. The AANEM sug-
gests that when performing needle EMG on such
patients, “. . .it is advisable to first examine the small,
superficial muscles, and to watch for bleeding prob-
lems. Prolonged pressure over the needle site will
usually produce hemostasis.”2 Restrictions based on
muscle location or depth are not specified.
There are only two case reports in the literature
of symptomatic hemorrhage related to needle EMG
of anticoagulated patients.4,8 Based on this type of
limited data, various strategies have been acknowl-
edged including complete avoidance of all needle
EMG,1 restrictions based on location of needle in-
sertion,1,2 temporary interruption of anticoagula-
tion,6 and use of small gauge needles.1 The goal of
this study was to survey academic EMG laboratories
regarding exclusions or special practices related to
EMG of patients who are anticoagulated or receiving
antiplatelet medications. Laboratories were also que-
ried regarding previous complications in these same
patient groups. Determining the majority practice
may help the personnel of individual laboratories to
examine their practices in a greater context. Exam-
ining current practice will also help to establish a
baseline for future clinical studies.
MATERIALS AND METHODS
Through the Accreditation Council on Graduate
Medical Education (ACGME) website, EMG labora-
tories associated with ACGME-approved neuromus-
cular fellowships were identified. A telephone survey
was administered to the laboratory director or a
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designee. Survey responses were recorded anony-
mously. The survey questions are found in the Ap-
pendix. Frequencies were calculated for all survey
responses. S-plus 7.0 for Windows (Insightful, Seat-
tle, Washington) was used for the analysis. This study
was approved by our Institutional Review Board.
RESULTS
A total of 60 EMG laboratories with ACGME-
approved fellowships were identified. Forty-seven
(78%) of the EMG laboratories responded. All ques-
tions were answered by each respondent. Only 17
(36%) of the laboratories reported having written
protocols regarding EMG in the setting of anticoag-
ulation.
Ten laboratories (21%) reported willingness to
examine cranial/facial, paraspinal, and all limb mus-
cles in anticoagulated patients. The frequency and
percent of willingness and unwillingness to perform
needle EMG on anticoagulated patients by muscle
group were as follows: cranial or facial muscles—yes:
23 (49%), no: 21 (45%), “it depends”: 3 (6%);
paraspinal muscles—yes: 13 (28%), no: 31 (66%), “it
depends”: 3 (6%). Sixteen (34%) replied that there
were some limb muscles that they were unwilling to
examine by EMG, whereas 31 (66%) were willing to
perform needle EMG on all limb muscles.
Four (9%) laboratories reported having at least
one prior bleeding complication requiring medical
or surgical intervention as a result of performing
needle EMG on an anticoagulated patient. One lab-
oratory reported having two previous complications;
the other three recalled a single complication. Two
of the four laboratories that disclosed a complication
continue to perform cranial/facial EMGs on antico-
agulated patients. None of the four laboratories per-
form paraspinal muscle EMGs on anticoagulated pa-
tients.
Nine (19%) of laboratories reported altering
some portion of the EMG in patients taking anti-
platelet agents. Most laboratories (87%) did not re-
quire patients to withhold antiplatelet agents prior
to EMG evaluation. No laboratory reported a prior
bleeding complication from EMG that required
medical or surgical intervention involving a patient
using antiplatelet agents.
DISCUSSION
This survey suggests that the majority of academic
EMG laboratories limit needle EMG examinations of
anticoagulated patients. Paraspinal muscles were the
most common muscle group avoided. Survey re-
sponses were quite varied and suggested significant
heterogeneity in clinical practices among laborato-
ries.
Serious hemorrhagic complications of needle
EMG appear to be rare events in anticoagulated
patients in the medical literature. The two reported
cases of bleeding complications in anticoagulated
patients includes an 81-year-old woman who pre-
sented 16 days after an EMG with a calf hematoma
and calf artery pseudoaneurysm.8 Her INR at the
time of the EMG had been 2.5. The second case was
a 64-year-old patient who presented 6 days after an
EMG with subcutaneous bleeding severe enough to
require a blood transfusion.4 There was an addi-
tional case of symptomatic bleeding into the iliop-
soas, and asymptomatic bleeding into the paraspinal
muscles, in a patient who had received an EMG and
was on subcutaneous heparin and aspirin; however,
this patient additionally had external trauma that
likely contributed to the bleeding.3 The current sur-
vey identified only five serious bleeding complica-
tions in anticoagulated patients, supporting the con-
cept that these are rare events.
Of the four symptomatic hemorrhages related to
needle EMG in the literature (excluding the case
confounded by trauma3), two occurred in non-anti-
coagulated patients: a paraspinal muscle hemato-
ma,5 and a calf muscle hematoma.6 Additionally, in
17 MRIs performed incidentally after an EMG in
non-anticoagulated patients, four small (1 cm3)
asymptomatic hemorrhages were identified among
45 muscles assessed.5 These findings indicate that
non-anticoagulated patients may also experience
hemorrhagic complications of EMG, and that asymp-
tomatic bleeding is not rare.
Although many more survey respondents avoid
needle EMG of the paraspinal muscles than other
muscle groups in anticoagulated patients, this is not
supported by the literature. Reports of hemorrhagic
complications are not clearly more frequent in the
paraspinal muscle location. Of the four cases in the
literature of symptomatic EMG-related hematomas
(again excluding the case confounded by trauma3),
two involved the paraspinal muscles,4,5 and two in-
volved the leg.6,8 Furthermore, one of the two leg
hematomas required surgical intervention, whereas
both paraspinal hematomas were managed medi-
cally. None of the hemorrhages resulted in any last-
ing neurological impairment. As the risk of compart-
ment syndrome in the leg exceeds that of the
paraspinal muscles, theoretically needle EMG of the
leg carries more risk than of the paraspinal muscles
in both anticoagulated and non-anticoagulated pa-
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tients. However, some electromyographers feel the
likelihood of prompt recognition of hemorrhage
into a paraspinal muscle seems substantially less than
recognition in a limb muscle.
We found no reports in the literature of bleeding
complications solely associated with EMG of a pa-
tient on antiplatelet therapy. The current survey sup-
ports this finding. Nonetheless, a sizable minority
(19%) of laboratories limit EMG examinations in
these patients. Given the highly prevalent use of
antiplatelet agents, limiting EMG studies in this set-
ting may deprive numerous patients of important
electrodiagnostic testing.7
This study has several limitations. First, the
survey responses may reflect the individual respon-
dent’s opinions and practice rather than that of
the entire laboratory. Second, accurate recollec-
tion of all prior complications may have been
contaminated by recall bias. Third, respondents
may have been hesitant to disclose complications
despite the anonymous recording of results. Last,
the apparently low risk of complications from
EMG of anticoagulated patients may be influenced
by the limitations imposed by electromyographers
on needle EMG, rather than representing an in-
herently low risk activity.
This survey of academic EMG laboratories sug-
gests that hemorrhagic complications related to nee-
dle EMG of anticoagulated patients is rare. It also
suggests that needle EMG of patients receiving anti-
platelet therapy is not associated with increased re-
ports of hemorrhagic complications. Lack of evi-
dence-based guidelines or a consensus statement
related to the approach to needle EMG of anticoag-
ulated patient likely explains the heterogeneity of
practices encountered in our survey. Electromyogra-
phers should weigh on a case-by-case basis the diag-
nostic value of the EMG with the apparently very low
risk of hemorrhagic complications in anticoagulated
patients. Furthermore, the development of a consen-
sus statement by the AANEM related to the perfor-
mance of needle EMG in anticoagulated patients
would be helpful to electromyographers and would
lead to more homogeneous practices.
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APPENDIX
Survey Questions
All questions require a “yes” or “no” answer except for questions
2 and 3, for which “it depends” can be answered.
1. Do you have written laboratory guidelines specific to needle
EMGs performed on anticoagulated patients (meaning war-
farin, IV heparin or heparinoids)?
2. Do you perform cranial or facial muscle needle EMG on
patients receiving anticoagulants?
3. Do you perform paraspinal muscle needle EMG on patients
receiving anticoagulants?
4. Are there any limb muscles you will not needle EMG in an
anticoagulated patient? If answer is “no”, skip to question 6.
5. What is your justification for exclusion of limb muscles for
needle EMG in these patients?
6. To your knowledge, has any anticoagulated patient had a
bleeding complication from an EMG in your laboratory re-
quiring medical or surgical intervention?
7. (If answer is “yes” to question 6) How many estimated pa-
tients?
8. Do you alter any portion of your needle EMG for a patient on
antiplatelet therapy?
9. Do you require patients to withhold antiplatelet therapy prior
to needle EMG?
10. To your knowledge, has any patient receiving an antiplatelet
agent had a bleeding complication from an EMG in your
laboratory requiring medical or surgical intervention?
11. (If answer is “yes” to question 10) How many estimated pa-
tients?
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